Enuresis. Nonorganic enuresis
Conditions
Interventions
Intervention 1: Intervention group: hydrochlorothiazide. Intervention 2: Control group: nasal spray desmopressin.
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 18 Years
Inclusion criteria
Inclusion criteria: All girls aged more than 5 years old and all boys over 6 years of age with diagnosis of primary monosymptomatic nocturnal enuresis referred to the nephrology clinic of children
Exclusion criteria
Exclusion criteria: Anatomical disorders lead to urinary incontinence such as neurogenic bladder, posterior ureteral valve and anatomical disorders of the ureter Metabolic disorders leading to polyuria such as diabetes mellitus and diabetes insipid secondary nocturnal enuresis polysymptomatic nocturnal enuresis Parental dissatisfaction adverse effects of drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resolved of Enuresis. Timepoint: Patients are followed up for a period of 6 months, and the outcome of the disease is the drying up of the child during sleep during medication three months and within three months after it, after discontinuation of drugs, in addition to monthly monitoring during the monthly visits to the families It will be explained if the child reports wetting the next day and if the child remains dry. Meanwhile, after the discontinuation of the medications within the next three months, follow-up and drying or returning of the enuresis will be considered. Method of measurement: Completion of follow-up questionnaires. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFahimeh Ahmadvand
Hamedan University of Medical Sciences
Outcome results
None listed